Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/236862793
CITATIONS
READS
261
3 authors:
Camilla Wiklund
Anne-Marie Bostrm
Karolinska Institutet
Karolinska Institutet
1 PUBLICATION 7 CITATIONS
SEE PROFILE
SEE PROFILE
Ingela Wiklund
Karolinska Institutet
48 PUBLICATIONS 610 CITATIONS
SEE PROFILE
Some of the authors of this publication are also working on these related projects:
1
Department of Biosciences and
Nutrition, Karolinska Institutet/
Stockholm University,
Stockholm, Sweden
2
Division of Nursing,
Department of Neurobiology,
Care Science and Society,
Karolinska Institutet, Stockholm,
Sweden
3
Department of Geriatric
Medicine, Danderyd Hospital,
Stockholm, Sweden
4
Division of Obstetrics and
Gynaecology, Department of
Clinical Sciences, Danderyd
Hospital, Karolinska Institutet,
Stockholm, Sweden
Accepted 8 July 2012
Correspondence to:
Dr Ingela E Wiklund
Department of Clinical Sciences,
Danderyd Hospital, Karolinska
Institutet, 182 88 Stockholm,
Sweden;
ingela.wiklund@bbstockholm.se
Abstract
Objective To update the evidence published in a previous
systematic review and meta-analysis that compared the
effect of breastfeeding on risk of coeliac disease (CD).
Material and methods A systematic review of observational studies published between 1966 and May 2004 on
the subject was conducted in 2005. This update is a systematic review of observational studies published
between June 2004 and April 2011. Pubmed, EMBASE
and Cinahl were searched for published studies that
examined the association between breastfeeding and CD.
Results After duplicates were removed 90 citations were
screened. Four observational studies were included in the
review. Two of three studies which had examined the
duration of breastfeeding and CD reported signicant
associations between longer duration of breastfeeding
and later onset of CD (OR ranged from 0.18 to 0.665).
Breastfeeding during the introduction of gluten to the
infant was reported to have a protective effect in two
studies.
Conclusions Our ndings support previous published
ndings that breastfeeding seems to offer a protection
against the development of CD in predisposed infants.
Breastfeeding at time of gluten introduction is the most signicant variable in reducing the risk. Timing of gluten
introduction may also be a factor in the development of CD.
Introduction
Coeliac disease (CD), also known as gluten sensitive
enteropathy, is a chronic autoimmune disease that affects
the small intestine in genetically predisposed individuals.
CD is induced by dietary intake of wheat gluten and
related prolamines, for example, in rye and barley. Most
of the individuals with CD carry a human leucocyte
antigen (HLA)-DQ2 or DQ8 haplotype gen but so does
about 30% of the general population.1 The prevalence of
CD is difcult to determine when the disease can be
asymptomatic for a long time and the diagnosed prevalence varies from 3 to 14 / 1000 children which means
that the environmental factors in the aetiology play a
crucial role.1 The disease is multifactorial and CD seems
to act as a combination of adaptive and innate immune
response to gluten. Studies show that one of the most
critical environmental factors is early infant feeding
practices with focus on breastfeeding.2 3
Breastfeeding is a subject for constant debate and
strong opinions, not whether or not it has positive
effects for the infant, but more as a question of how
good it is and for what. As early as in the 1950s, breastfeeding was suggested to have a protective effect and
that breastfed infants had a later onset of CD. For the
last decades epidemiological studies have shown
breastfeeding to be a crucial element in allergy development.4 The mechanisms underlying the aetiology are not
fully understood and therefore nor the mechanisms
behind the protective effect. Continuing breastfeeding at
time of gluten introduction has been suggested to limit
the amount of gluten the child receives and thereby
decreasing the chance of developing the symptoms of
CD. Another possible explanation is that the milk in
itself protects against gastrointestinal infections.2 4 Such
infections may lead to increased permeability which
allows gluten to pass on into the lamina propia triggering the process of CD in susceptible individuals.4
Whatever the mechanism might be, breastfeeding is the
most important environmental factor in CD development
for an infant. That makes this area of research important
since there are indications that breastfeeding rates are
declining. For example, in the Stockholm area in
Sweden the number of children exclusively breastfeeding have declined by 10.5% in the last 15 years, if this
has an effect on prevalence of CD is yet to be seen.5
The WHO declared in a systematic review from 2002
that one of their goals is that 80% of all the children in
the world should be exclusively breastfed for 6 months.6
Sweden and many other European countries adapted
this recommendation, which means that other foods,
such as wheat, should be introduced after 6 months.
Lately, it has been questioned whether this is the best
way of introducing possibly allergenic foods. Models in
animals suggest that oral tolerance is an allergen-driven
process and that there is a critical early window when
exposure to proteins is essential to the development of
this process.7 The timing for this window for oral allergen tolerance is not fully established in humans but
current studies point towards it being between 4 and
6 months.7 8 This makes the timing of gluten introduction and whether it is introduced under the protection
of breastfeeding or not a signicant question.
In 2005, Akobeng et al2 conducted a systematic
review and a meta-analysis with the aim to explore the
potential association between breastfeeding and reduced
risk of CD. The following outcomes were examined: (1)
the effect of breastfeeding compared with no breastfeeding; (2) the effect of duration of breastfeeding and (3)
the effect of breastfeeding at time of introduction of
dietary gluten. Akobeng et al2 systematically searched
various databases for studies examining these effects
published from 1966 to May 2004. The result of the
study suggested that breastfeeding may offer protection
against the development of CD. A meta-analysis of four
of the six studies indicated that children being breastfed
at the time of gluten introduction had a 52% reduction
in risk of developing CD compared with their peers who
were not breastfed at the time of gluten introduction.
Copyright Article author (or their employer) 2012. Produced by BMJ Publishing Group Ltd under licence.
Therapeutics
This study aims to update the evidence published in the
systematic review with articles published from June
2004 to April 2011 in order to evaluate possible developments in this research eld. Following research questions guided the study: (1) the effect of breastfeeding
compared with no breastfeeding; (2) the effect of duration of breastfeeding and (3) the effect of breastfeeding
at the time of introduction of dietary gluten.
Data extraction
Information and data on relevant features and results
was extracted from each of the included studies. When
data was missing or unclear in the published paper we
emailed the authors for more information. None of the
authors responded on our requests.
Data analysis
In the included studies many different assessments for
breastfeeding and statistical tests were used, and the
presentation of data prevented us from performing a
meta-analysis. Therefore, the ndings from the articles
are presented in narrative form.
Results
Types of studies
Included studies were observational studies and one
casecontrol study with the same inclusion criteria as in
the systematic review: (1) compared risk of CD in people
who were breastfed with risk in those who were not
breastfed, or compared risk of CD according to duration
of breastfeeding; (2) had used histological criteria for
diagnosing CD; (3) had controlled for potential confounders by matching in the study design or used risk
adjustment in the analysis and (4) had provided sufcient data to allow the reconstruction of 2 2 tables to
determine relative risks or OR with 95% CI. Only articles
written in English were included.
Search strategy
Pubmed, EMBASE and Cinahl were systematically
searched for articles and studies published between June
2004 and April 2011 with the search strategy presented
in table 1. The search was conducted on 25 April 2011.
The reference lists of the relevant citations found in this
search was examined for further potentially appropriate
articles.
Assessment of study eligibility
The rst author assessed each article for eligibility using
the inclusion criteria above. Unclear citations were discussed with the other authors and agreement reached by
consensus.
Assessment of methodological quality
The authors independently rated methodological quality
of selected studies using the Critical Appraisal Skills
Programme (Oxford, UK) tool for observational studies.9
Each study was grade as A (low risk of bias), B (moderate
risk of bias) or C (high risk of bias) according to published
criteria.10 Disagreements were resolved by consensus.
1 OR 2
4 OR 5
3 AND 6
Therapeutics
Figure 1
Flowchart of selection of the included studies based on Prisma 2009 Flow Diagram.
Therapeutics
Table 2 Methodology of included studies (summary)
Confounding
factors
considered
Sample
size
Retrospectively
analysed
medical records
Age, sex
89 cases
724 months,
median
14 months
Within
cohort
Questionnaire
Age, sex
141 cases
8.4 years
Children with
CD, Denver
metropolitan
area
All
CD-negative
children in
cohort
Interview,
questionnaire
Ethnicity,
infant diet
choices
51 cases,
1509
controls
4.7 years
All new
CD-cases
2006-06
2007-05, 39
hospitals,
Spain
Children
paired for
age and sex
Questionnaire
993
cases,
744
controls
3.7 years
Not assessed
Reference
(country)
Case
selection
Control
selection
Exposure
measurement
Radlovic
et al
(Serbia)
Children with
coeliac
disease (CD),
UniChildrens
hospital,
Belgrade
Within
cohort
DAmico
et al (the
USA)
Children
under age 20
with CD, 30
different
states, USA
Norris
et al (the
USA)
Roman*
(Spain)
Age
Methodological
quality
*A conference report whose abstract was published but not yet the whole study.
A, low risk of bias; B, moderate risk of bias; C, high risk of bias.
Discussion
The aim of this study was to update the previous published evidence in a systematic review and meta-analysis
examining the association between breastfeeding and
reduced risk of CD.2 The review suggested that breastfeeding may offer protection against the development of
CD and that children being breastfed at time gluten
introduction had a 52% reduction in risk of developing
CD compared with their peers who were not breastfed at
the time of gluten introduction.2 In this updated article
the results point in the same direction although the evidence is weaker. In the original review2 all included
studies were casecontrol studies, and in this update
only one casecontrol study was available. The remaining studies were observational studies reporting data in
various ways preventing us conducting a meta-analysis.
During the last 7 years there has been few studies
Therapeutics
conducted in this research eld which prevent a reliable
update of the meta-analysis. Two review articles
(although not systematic reviews) have been recently
published in support of our ndings; Silano et al8 conrms a negative correlation between the duration of
lu
breastfeeding and development of CD and Selimog
et al4 states that the most important preventive strategies
include the encouragement of breastfeeding. Our ndings in combination with the previous ndings from
Akobeng et als2 systematic review and the two recent
published review articles make its safe to say that
breastfeeding have an important role in delaying and/or
preventing the development of CD.
The ndings on timing of gluten introduction and
the circumstances at this point is also crucial. It is not
clear from these results (or previous ones) if breastfeeding provides a permanent effect against CD or if it
delays the symptoms. One study found no correlation
neither between the duration of breastfeeding nor if
gluten was introduced under the protection of breastfeeding.18 This study had relatively few cases (children
with CD; n=51) and this may explain why no correlation
was identied. The cases in this study were recruited
from a large birth cohort in Denver, Colorado, USA.
Cord blood samples were collected and screened and
infants with a specic HLA genotype was invited to participate. This means that these children and their parents
were selected because of their high risk of developing
autoimmune diseases such as CD. No dietary advice was
given to these families but it is impossible to rule out
that this did not affect the choice of infant diet. It was a
prospective observational study and recall bias is therefore a minimal risk.
Breastfeeding, infant feeding, weaning and everything related to it are subjects where everyone has an
opinion and where medical facts are combined with traditions. There are national differences as well as cultural
and personal beliefs between how parents choose to
feed their children. In the previous systematic review the
study objects originate from three different countries;
Italy, Germany and Sweden.2 In this update the included
studies are conducted in three other countries; Serbia,
the USA and Spain. Together these six countries represent widely shifting prevalence of breastfeeding with
Italy and Serbia with the lowest percentage were only
18% and 23% of the infants are breastfeeding at
4 month and with Sweden in the top where practically
all children are breastfed during the rst week and 60%
still at 4 months of age. USA and Spain are somewhere
in-between with rates at 33% and 40% at 4 months.19 20
Despite these differences nearly all studies have the
same results; when it comes to CD, breastfeeding seems
to have a protective effect against the development. The
previously published evidence are conrmed and reinforced by the new ndings in this update and one could
assume that future studies will continue to conrm this
nding.
Sweden is a country with one of the highest rates of
breastfeeding in the world; however, the rates are dropping. In a report from 2010 conducted in the Stockholm
area results showed that breastfeeding rates are declining
at both 4 months as well as the share of infants being
breastfed at age 1 week.5 The reason for this decline is
Therapeutics
included studies accounted for socioeconomic status to be
a confounding factor although this is a crucial factor for
diet choice. Furthermore, the published studies provided
only data for narrative presentation and we could not
conduct a meta-analysis. Thus, the ndings from this
updated review must be interpreted with caution.
References
1. Mylus A, Ivarsson A, Webb C, et al. Celiac disease revealed in
3% of Swedish 12-year-olds born during an epidemic. J Pediatr
Gastroenterol Nutr 2009;49:1706.
2. Akobeng AK, Ramanan AV, Buchan I, et al. Effect of breast
feeding on risk of coeliac disease: a systematic review and
meta-analysis of observational studies. Arch Dis Child
2006;91:3943.
3. Ivarsson A. The Swedish epidemic of coeliac disease explored
using an epidemiological approachsome lessons to be learnt.
Best Pract Res Clin Gastroenterol 2005;19:42540.
lu MA, Karabiber H. Celiac disease: prevention and
4. Selimog
treatment. J Clin Gastroenterol 2010;44:48.
5. Idenstedt U, Zwedberg S. Tillmatning av nyfdda barn p BB i
Stockholms lns landsting 2010. Formula feeding of newbornes
at maternity wards in Stockholm. Stockholm County Council.
Report published in Swedish.
6. Kramer MS, Kakuma R. The optimal duration of exclusive
breastfeeding. A systematic review. Adv Exp Med Biol
2004;554:6377.
7. Prescott SL, Smith P, Tang M, et al. The importance of early
complementary feeding in the development of oral tolerance:
concerns and controversies. Pediatr Allergy Immunol
2008;19:37580.